Gabelli Funds’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Gabelli Funds’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,392,732	Closed	-$73.1M	–	1289
2020 Q3	$73.1M	Buy	+1,392,732	New	+$57.7M	0.57%	33

Gabelli Funds's MNTA Position: Q4 2020 in Review

Gabelli Funds sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 1,392,732 shares — an estimated $73.1M sold.

Gabelli Funds first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $73.1M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Gabelli Funds reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Gabelli Funds sold 1,392,732 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $73.1M.
Gabelli Funds first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
Gabelli Funds's Momenta Pharmaceuticals, Inc. position peaked at $73.1M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Gabelli Funds's 13F filing for Q4 2020, filed 5 Feb 2021.